Survive and Thrive in the Current Fundraising Environment
Market distress brings challenges, but also opportunities. In this session, Ballard Spahr experts will discuss what life sciences companies need to know about the legal aspects of fundraising, including
- Deal terms and how they are changing
- Prioritizing Programs
- IP as an asset
Moderator: Ryan Udell, Partner, Ballard Spahr
Kimberly Klayman, Partner, Ballard Spahr
Lorenzo Pellegrini, Managing Partner, Hatch Biofund
Zygmunt Porada, Chief Executive Officer, DirectSync Surgical
CLE Credits: This program is approved for 1.0 in CA, NY, & PA; and 1.2 NJ. Uniform Certificates of Attendance will also be provided for the purpose of seeking credit in other jurisdictions. Any questions regarding the CLE Credits, please contact Donna Calvin, Professional Development Specialist for CLE, Ballard Spahr, at [email protected].
9:00am - 10:00am: Welcome & Discussion
10:00am - 10:30am: Breakout Sessions
Refunds and Questions:
- Refund/cancellation policy: This program is offered free of charge to LSPA Members in good standing. As such refunds are not applicable.
- Questions about Membership: If you are not sure you are a member or whether your membership dues are up-to-date, please contact Lois Stephens, Membership Director, [email protected]
- Questions about the Event: Contact Natalie George - [email protected]
Ballard Spahr LLP is an AmLaw 100 law firm with more than 600 attorneys in 15 US offices. We provide results-driven counsel and exceptional service in more than 50 practice areas. We are a destination practice for life sciences businesses, serving them from innovation to commercialization. Our life sciences lawyers—many of whom hold advanced degrees in the sciences—understand the complex, industry-specific issues at play. Our dedicated team includes lawyers who focus on corporate, litigation, IP and real estate matters specific to the life sciences industry.